Analyzing serum EPO levels in a larger cohort of patients with HUS and acute kidney injury of other origins may help to further elucidate whether the degree of renal dysfunction and/or injury correlates with the endogenous EPO production. The gene discussed is EPO; the disease is hemolytic-uremic syndrome.